Related Experiment Video

Updated: Mar 18, 2026

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

13.8K

Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants

Hsin-Hsu Chou1, Mei-Yung Chung2, Xiao-Guang Zhou3

  • 1Department of Pediatrics, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Tainan, Taiwan; Department of Applied Life Science & Health, College of Human Ecology, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.

Pediatrics and Neonatology
|June 28, 2016
PubMed

Insights

Erythropoietin (EPO) administration does not increase the risk of retinopathy of prematurity (ROP) in preterm infants. This meta-analysis found no significant association between EPO treatment and ROP development, regardless of treatment timing.

Area of Science:

  • Neonatal Medicine
  • Ophthalmology
  • Pharmacology

Background:

  • Erythropoietin (EPO) is used to prevent anemia in premature infants.
  • EPO administration may potentially increase the risk of retinopathy of prematurity (ROP).
  • Early EPO treatment might offer protection against retinal neovascularization damage.

Purpose of the Study:

  • To determine if EPO administration elevates the risk of ROP in preterm infants through a meta-analysis.

Main Methods:

  • A systematic search of major databases (MEDLINE, PubMed, CINAHL, Cochrane) was conducted.
  • Included studies were randomized controlled trials involving preterm infants and EPO treatment.
  • Studies were stratified into early (before 8 days) and late (8-28 days) EPO initiation groups.

Main Results:

  • Thirteen studies with 1999 infants were analyzed.
  • EPO administration showed no significant increase in ROP risk for any stage or severe ROP (Stage ≥3).
  • This finding was consistent for both early and late EPO treatment groups, with no evidence of publication bias.

Conclusions:

  • EPO administration does not significantly increase the risk of ROP in premature infants.
  • Further research should incorporate confounding factors to clarify EPO's impact on ROP.
Abstract

Keywords:
erythropoietinmeta-analysisretinopathy of prematurity

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.6K
Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis06:40

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis

Published on: September 9, 2014

15.9K

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.6K
Erythropoiesis01:14

Erythropoiesis

3.9K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
693